Faeth Therapeutics Inc.
FTH | NASDAQ
$18.69
-$0.06 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$18.69
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:23 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 551K | 571K | 1.81M | 685K | 209K |
Gross Profit | n/a | -551K | -571K | -1.81M | -685K | -209K |
Operating Income | -22.29M | -31.66M | -37.06M | -49.12M | -37.48M | -19.45M |
Interest Income | 1.24M | 2.55M | 3.62M | 1.78M | 800K | 1.69K |
Pretax Income | -21.09M | -30.16M | -34.1M | -48.59M | -36.79M | -20.1M |
Net Income | -21.09M | -30.16M | -34.1M | -48.59M | -36.79M | -20.1M |
Selling & General & Admin | 11.33M | 12.49M | 18.77M | 17.73M | 15.14M | 7.53M |
Research & Development | 10.96M | 18.63M | 18.3M | 29.58M | 21.66M | 11.92M |
Other Expenses | n/a | n/a | -571K | n/a | n/a | -209K |
Operating Expenses | 22.29M | 31.11M | 36.49M | 47.31M | 36.8M | 19.24M |
Interest Expense | 32K | 90K | 144K | 219K | 670K | 1.69M |
Selling & Marketing Expenses | n/a | n/a | 100K | n/a | n/a | n/a |
Cost & Expenses | 22.29M | 31.66M | 37.06M | 49.12M | 37.48M | 19.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.26M | 1.26M | 1.4M | 1.54M | 1.39M | 1.53M |
Shares Outstanding (Diluted) | 1.26M | 1.26M | 1.4M | 1.54M | 1.39M | 1.53M |
EPS (Basic) | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 | -13.21 |
EPS (Diluted) | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 | -13.21 |
EBITDA | -20.91M | -29.52M | -33.39M | -46.56M | -35.44M | -18.2M |
EBIT | -21.05M | -30.07M | -36.96M | -48.37M | -36.12M | -18.41M |
Depreciation & Amortization | 139K | 551K | 3.68M | 1.81M | 685K | 209K |
Add to Watchlist
Select watchlists to add or remove FTH